Correlation Between Summit Therapeutics and Ryanair Holdings

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Ryanair Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Ryanair Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Ryanair Holdings PLC, you can compare the effects of market volatilities on Summit Therapeutics and Ryanair Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Ryanair Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Ryanair Holdings.

Diversification Opportunities for Summit Therapeutics and Ryanair Holdings

0.36

Correlation Coefficient

Summit Therapeutics  Ryanair Holdings

Weak diversification

The 3 months correlation between Summit and Ryanair is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Ryanair Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryanair Holdings PLC and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Ryanair Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryanair Holdings PLC has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Ryanair Holdings go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Ryanair Holdings

Given the investment horizon of 90 days Summit Therapeutics PLC is expected to under-perform the Ryanair Holdings. In addition to that, Summit Therapeutics is 2.6 times more volatile than Ryanair Holdings PLC. It trades about -0.04 of its total potential returns per unit of risk. Ryanair Holdings PLC is currently generating about 0.0 per unit of volatility. If you would invest  4,535  in Ryanair Holdings PLC on September 23, 2024 and sell it today you would lose (65.00) from holding Ryanair Holdings PLC or give up 1.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Ryanair Holdings PLC

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Ryanair Holdings PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ryanair Holdings PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Ryanair Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Summit Therapeutics and Ryanair Holdings

The main advantage of trading using opposite Summit Therapeutics and Ryanair Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Ryanair Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryanair Holdings will offset losses from the drop in Ryanair Holdings' long position.

The idea behind Summit Therapeutics PLC and Ryanair Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.